-
JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management
Despite the rising incidence of MASLD-related HCC, studies focusing on the clinical characteristics, survival, and prognosis of non-cirrhotic MASLD patients remain limited. The study aimed to uncover clinical features and…
-
PALACE Study: Long-Term Follow-Up Data After Removal of Penicillin Allergy Labels
The Penicillin Allergy Clinical Decision Rule (PALACE) study is the first international, multicenter randomized clinical trial to demonstrate that direct oral penicillin (DOC) in adult patients with low-risk penicillin allergy…
-
Early Detection of Minimal Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA
Recently, Professor Xiaofan Zhu, Director of the Division of Pediatric Hematology and Oncology Center at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Associate Chief Physician Doctor Min Ruan and Attending Doctor LiPeng Liu collaborated on a study titled “Early Detection of Minimal Residual Disease and Risk Stratification for Children…
-
Professor Yunsong Yu ‘s Team: Molecular Epidemiological Characteristics and Treatment Strategies for Ertapenem-Monotherapy Resistant CRE Strains | ESC
Phenotypic and Genotypic Characteristics of Ertapenem-Monotherapy Resistant Carbapenem-Resistant Enterobacterales (Abstract No.: P1469) Background: Carbapenem-resistant Enterobacterales (CRE) are one of the major global public health threats. In recent years, reports of…
-
Breakthrough in Vebreltinib Research: A New Hope for METex14-Mutated NSCLC Patients!
Vebreltinib, a highly potent and selective c-MET (mesenchymal-epithelial transition) inhibitor, offers a promising treatment option for patients with MET exon 14 skipping mutation (METex14) in non-small cell lung cancer (NSCLC). Can it provide a safe and effective therapy for these patients?
-
Frontiers in Gynecologic Oncology | Can Severe Endometriosis Significantly Increase the Risk of Ovarian Cancer?
A large population-based cohort study led by Dr. Mollie E. Barnard from the Huntsman Cancer Institute at the University of Utah has found that women with endometriosis have an overall higher risk of ovarian cancer, with the risk being significantly elevated in those with severe types of endometriosis. This study, published in the journal of…
-
Lung Cancer Guidelines: ASCO Updates Stage III NSCLC Guidelines Based on LAURA Trial Data, Including Osimertinib
The Phase 3 Non-Small Cell Lung Cancer (NSCLC) Treatment ASCO Guidelines has recently been updated, with the revisions based on the results of the Phase 3 LAURA trial. The findings were presented at the 2024 ASCO Annual Meeting and published simultaneously in the New England Journal of Medicine [1, 2]. The new guidelines include a…
-
A Novel Magnetic Nanoparticle-Based Rapid Drug Sensitivity Testing Method Achieves 95% Consistency
This technology involves magnetic nanoparticles coated with synthetic plasma peptides that can bind to bacteria in whole blood. Magnetism is used to separate the bacteria bound to the nanoparticles, and…
Connecting Medical Expertise through Media